01/03/23 8:00 AMNYSE : ELAN conferencesElanco to Participate in the 41st Annual J.P. Morgan Healthcare ConferenceElanco Animal Health Incorporated will participate in the 41 st Annual J.P. Morgan Healthcare Conference on Tuesday, January 10, 2023. Elanco Animal Health is a global leader in animal health dedicated to innovating and delivering products and services to prevent and treat disease in farm animals and pets, creating value for farmers, pet owners,...RHEA-AIneutral
12/09/22 10:48 AMNYSE : ELAN fda approvalElanco Announces FDA Approval of Bexacat™ (bexagliflozin tablets) – the First-of-its-Kind Oral Feline Diabetes Treatment OptionToday Elanco Animal Health announced the U.S. Food and Drug Administration approved Bexacat™, the first orally administered prescription medication to improve glycemic control in cats with diabetes mellitus, expanding Elanco’ s innovative feline portfolio while addressing an unmet need for this chronic condition in adult cats. An estimated 600,000 cats...RHEA-AIneutral
11/16/22 8:00 AMNYSE : ELAN conferencesElanco to Participate in Evercore ISI 5th Annual HealthCONx ConferenceElanco Animal Health Incorporated will participate in the Evercore ISI 5 th Annual HealthCONx Conference on Tuesday, November 29, 2022. Elanco Animal Health Incorporated is a global leader in animal health dedicated to innovating and delivering products and services to prevent and treat disease in farm animals and pets, creating value for farmers, pet...RHEA-AIneutral
11/08/22 6:30 AMNYSE : ELAN Elanco Animal Health Reports Third Quarter 2022 ResultsElanco Animal Health Incorporated today reported financial results for the third quarter of 2022, provided guidance for the fourth quarter of 2022, and updated guidance for the full year 2022.. Environmental conditions have worsened from our assumptions in August causing us to reduce our full year financial outlook to reflect additional foreign...RHEA-AIneutral
10/11/22 8:00 AMNYSE : ELAN earningsElanco Confirms Date and Conference Call for Third Quarter 2022 Financial Results AnnouncementElanco Animal Health Incorporated will announce its third quarter 2022 financial results on Tuesday, November 8, 2022. Elanco Animal Health Incorporated is a global leader in animal health dedicated to innovating and delivering products and services to prevent and treat disease in farm animals and pets, creating value for farmers, pet owners,...RHEA-AIneutral
09/08/22 8:00 AMNYSE : ELAN managementElanco Announces Changes to its Board of DirectorsElanco Animal Health Incorporated announced today that Scott Ferguson, founder and managing partner of Sachem Head Capital Management LP, is stepping down from the Board of Directors in connection with Ferguson and Sachem Head refocusing his time across other Sachem Head Board commitments. Looking ahead, we will continue to benefit from the expertise of...RHEA-AIvery positive
09/01/22 8:00 AMNYSE : ELAN conferencesElanco to Participate in Morgan Stanley 20th Annual Global Healthcare ConferenceElanco Animal Health Incorporated will attend the Morgan Stanley 20th Annual Global Healthcare Conference on Monday, September 12, 2022. Elanco Animal Health Incorporated is a global leader in animal health dedicated to innovating and delivering products and services to prevent and treat disease in farm animals and pets, creating value for farmers, pet...RHEA-AIneutral
08/16/22 8:00 AMNYSE : ELAN Elanco Releases 2021 Environmental, Social and Governance Report Highlighting Progress on Healthy Purpose™ GoalsElanco Animal Health Incorporated today released its 2021 Environmental, Social and Governance Report“ Changing The World One Animal at a Time” highlighting the company’ s progress on relevant ESG topics and metrics. The 2021 report outlines the company’ s approach to sustainability, called Elanco’ s Healthy Purpose™, and goals– which align with the United...RHEA-AIvery positive
08/08/22 6:30 AMNYSE : ELAN Elanco Animal Health Reports Second Quarter 2022 ResultsElanco Animal Health Incorporated today reported financial results for the second quarter of 2022, provided guidance for the third quarter of 2022, and updated guidance for the full year 2022.. In July, we launched Zorbium, a feline pain product in the U.S., and are seeing a strong start. Within the next two to four months, we expect to make regulatory submissions...RHEA-AIneutral
07/18/22 6:30 AMNYSE : ELAN earningsElanco Confirms Date and Conference Call for Second Quarter 2022 Financial Results AnnouncementElanco Animal Health Incorporated will announce its second quarter 2022 financial results on Monday, August 8, 2022. Elanco Animal Health Incorporated is a global leader in animal health dedicated to innovating and delivering products and services to prevent and treat disease in farm animals and pets, creating value for farmers, pet owners, veterinarians,...RHEA-AIneutral